Alto Pharmacy, a digital pharmaceutical startup based in San Francisco that’s backed by SoftBank Group Corp., agreed to be ...
We think CR Pharma has a weaker financial position compared with the top three medical distributors. Similar to other pharmaceutical distributors, accounts receivable make up a large portion of its ...
Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...
Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.
Discover Corvus Pharmaceuticals' Q4 2024 earnings insights, highlighting soquelitinib's trial progress, upcoming milestones for 2025, and robust ...
StockStory.org on MSN6d
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals StocksThe end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
StockStory.org on MSN6d
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs PeersWrapping up Q4 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results